David Bouchey Stock Analyst Profile - Aegis Capital Research Coverage - Stocknear

David Bouchey

Stock Analyst at Aegis Capital

(1.5)
# 3392
Out of 5,493 analysts
7
Total ratings
Success rate
Average return

5 Stocks

Name Action PT Current % Upside Ratings Updated
SBFM Sunshine Biopharma
Reiterates: Buy
15 15
1.46 927.4% 2 Dec 5, 2024
STSS Sharps Technology
Initiates Coverage On: Buy
105600
6.72 1571328.57% 1 May 9, 2023
ATXI Avenue Therapeutics
Initiates Coverage On: Buy
2400
0.83 289056.63% 1 Apr 3, 2023
IINN Inspira Technologies...
Maintains: Buy
10 13
1.31 892.37% 1 Jan 25, 2023
RMTI Rockwell Medical
Downgrades: Outperform
121
1.27 9427.56% 2 Oct 19, 2018